Salesforce.com ( CRM)rated new outperform at FBN. CRM was initiated with an outperform rating, FBN Securities said. $210 price target. Successfully growing shares in the SaaS market. Marathon Oil ( MRO) price target increased at Citi. Based on a normalized valuation for a pure-play E&P company, the MRO price target was increased to $40, said Citigroup. Adobe Systems price target and estimates increased at UBS through 2014. The migration to a subscription model continues to be better-than-expected, said UBS. New price target is $46. Cardinal Health price target and estimates cut at UBS. The loss of the contract with Walgreens was disappointing and makes the CVS contract renewal even more important, said UBS. Price target goes to $50. Crestwood Midstream ( CMLP) estimates increased at UBS in 2014. The company is leveraging Enerven compression deal to further Marcellus build-out, benefiting 2014, said UBS. The Hartford ( HIG) estimates increased at UBS. Price-to-book multiple expansion will continue with improvements in ROE and earnings mix shifts. Microsoft ( MSFT) estimates reduced at BMO through 2014. Company will be hurt by lower PC unit sales, BMO Capital said. Market perform rating and $30 price target. Walgreens price target and estimates increased at UBS through 2014, said UBS. The deal with ABC will enhance EPS. Price target is now $51. Williams-Sonoma ( WSM) estimates reduced at UBS on an outlook that was below consensus estimates. Operating margins will be flat to negative this year, said UBS. Symantec price target increased at UBS to $28. Management's EPS growth outlook justifies a higher multiple, said UBS. >To submit a news tip, email: firstname.lastname@example.org.